NEW YORK (GenomeWeb News) – Maternal and fetal biotechnology firm Carmenta Bioscience today said it has acquired an option for a worldwide, exclusive license from Stanford University for technology aimed at diagnosing and predicting preeclampsia.
A team of researchers at Boston Children's Hospital has identified a pair of urine biomarkers — filamin C and meprin A — that could be the first to provide accurate early diagnosis of Kawasaki disease.
NEW YORK (GenomeWeb News) – Trovagene today announced it has granted to Genoptix a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia.
NEW YORK (GenomeWeb News) – Aushon BioSystems said today that it has appointed AH Diagnostics to be its exclusive distributor in Scandinavia, effective immediately.
Diagnostics company 20/20 GeneSystems presented data last week showing high sensitivity and specificity for its protein biomarker test to predict response to Herceptin (trastuzumab) in HER2-positive breast cancer patients.
NEW YORK (GenomeWeb News) – The British non-profit Parkinson's UK plans to provide £750,000 ($1.2 million) for research to find protein biomarkers for diagnosing and measuring the progress of Parkinson's disease.
NEW YORK (GenomeWeb News) – Isogen Life Science will distribute Axela's multiplex biomarker platforms in Benelux and Spain under an agreement announced by the firms today.
NEW YORK (GenomeWeb News) – BG Medicine reported a 44 percent drop in first-quarter revenues year over year as its service revenues plummeted but its product revenues rose sharply.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
